← SynDRA
MOMETASONE
SynDRA canonical compound SYN0023586 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | NR3C1 |
| Mechanism of action | glucocorticoid receptor agonist |
| Indication | corticosteroid-responsive dermatoses |
| Disease area | dermatology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Elocom
- Mometasona
- Mometasonum
- Mometasona [Spanish]
- Mometasonum [Latin]
- Asmanex (TN)
- Elocon (TN)
- Mometasone (INN)
- Nasonex (TN)
- Twisthaler (TN)
- (+)-Mometasone
- (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- (9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- 9,21-dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
- mometasone furoate impurity g (ep impurity)
- LAS-41002
- monovo
- las41002
- 8HR4QJ6DW8
- CHEBI:6970
- RefChem:55659
- D07AC13
- D07XC03
- DTXCID80820066
- R01AD09
- R03BA07
- Mometasone furoate EP impurity G
- MOMETASONE [INN]
- C22H28Cl2O4
- mometazone
- Mometasone, nasal
- Elocon (topical)
- Mometasone, inhaled
- Mometasone, topical
- Mometasone (Standard)
- Mometasone [INN:BAN]
- MOMETASONE [VANDF]
- UNII-8HR4QJ6DW8
- SCHEMBL4485
Look up MOMETASONE in the interactive SynDRA portal →